Defective Glial Maturation in Vanishing White Matter Disease
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Vanishing white matter (VWM) disease is a genetic leukoencephalopathy linked to mutations in the eukaryotic translation initiation factor 2B. It is a disease of infants, children, and adults who experience a slowly progressive neurologic deterioration with episodes of rapid clinical worsening triggered by stress and eventually leading to death. Characteristic neuropathologic findings include cystic degeneration of the white matter with scarce reactive gliosis, dysmorphic astrocytes, and paucity of myelin despite an increase in oligodendrocytic density. To assess whether a defective maturation of macroglia may be responsible for the feeble gliosis and lack of myelin, weinvestigated the maturation status of astrocytes and oligodendrocytes in the brains of 8 VWM patients, 4 patients with other white matter disorders and 6 age-matched controls with a combination of immunocytochemistry, histochemistry, scratch-wound assays, Western blot, and quantitative polymerase chain reaction. We observed increased proliferation and a defect in the maturation of VWM astrocytes. They show an anomalous composition of their intermediate filament network with predominance of the δ-isoform of the glial fibrillary acidic protein and an increase in the heat shock protein αB-crystallin, supporting the possibility that a deficiency in astrocyte function may contribute to the loss of white matter in VWM. We also demonstrated a significant increase in numbers of premyelinating oligodendrocyte progenitors in VWM, which may explain the coexistence of oligodendrocytosis and myelin paucity in the patients' white matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification
Zhou, Q., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00677-3 · Cited by 1,059 · cited 1×
“Olig2 in glial cells inhibits astrocyte differentiation, thereby allowing the cells to maintain an undifferentiated state or to develop into myelinating oligodendrocytes (28).”
BackgroundPDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice
Rivers, L. E., Young, K. M., Rizzi, M., Jamen, F., Psachoulia, K., Wade, A., Kessaris, N., & Richardson, W. D. (2008) · Nature Neuroscience · doi:10.1038/nn.2220 · Cited by 961
Dawson, M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00210-0 · Cited by 927 · cited 1×
“Oligodendrocytes are the cell population in the CNS with the most significant turnover, and as such, all stages of precursor cells exist through adult life (44, 49).”
BackgroundPolydendrocytes (NG2 cells): multifunctional cells with lineage plasticity
Nishiyama, A., Komitova, M., Suzuki, R., & Zhu, X. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2495 · Cited by 865 · cited 16×
“Because PDGFR> alone did not stain a proportion of cells in the VWM white matter, tissue sections were additionally probed against another nominal OPC marker, chondroitin sulfate proteoglycan (NG2).”
BackgroundInfluentialDimou, L., Simon, C., Kirchhoff, F., Takebayashi, H., & Götz, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2831-08.2008 · Cited by 551 · cited 15×
“However, the finding of significantly reduced amounts of myelin structural proteins and lipids previously detected by immunohistochemistry and direct quantification (2, 8, 41, 58) suggests that only few OPCs can differentiate into myelinating oligodendrocytes in the affected white matter of VWM patients.”
ResultInfluentialEndogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544 · cited 1×
“Adult OPCs can efficiently generate new mature oligodendrocytes in early MS lesions (44, 53), as well as after acute experimental demyelination (54, 55).”
BackgroundAstrocyte intermediate filaments in CNS pathologies and regeneration
Pekny, M., & Pekna, M. (2004) · The Journal of Pathology · doi:10.1002/path.1645 · Cited by 420 · cited 1×
“As such, the concurrent induction of nestin and upregulation of GFAP and vimentin are hallmarks of reactive astrocytosis, both experimentally and in disease (19).”
BackgroundIntermediate Filament Protein Partnership in Astrocytes
Eliasson, C., Sahlgren, C., Berthold, C.-H., Stakeberg, J., Celis, J. E., Betsholtz, C., Eriksson, J. E., & Pekny, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23996 · Cited by 357
Multiple Sclerosis: Remyelination in Acute Lesions
Raine, C. S., & WU, E. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00003 · Cited by 285
Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion
Watanabe, M., Toyama, Y., & Nishiyama, A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10338 · Cited by 261 · cited 1×
“Adult OPCs can efficiently generate new mature oligodendrocytes in early MS lesions (44, 53), as well as after acute experimental demyelination (54, 55).”
Background
Cited by
Hol, E. M., & Pekny, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.004 · Cited by 917
Self-citationWang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586
“…may prove to be critically important therapeutic vectors for diseases of primarily astrocytic pathology (Krencik et al., 2011), such as Alexander disease and the vanishing white-matter disorders (Bugiani et al., 2011), in which myelin loss occurs but may be secondary to astrocytic dysfunction.”
BackgroundSelf-citationvan der Knaap, M. S., & Bugiani, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1739-1 · Cited by 403
“5l) [30] and possibly die by apoptosis [28, 254].”
BackgroundSelf-citationKamphuis, W., Mamber, C., Moeton, M., Kooijman, L., Sluijs, J. A., Jansen, A. H. P., Verveer, M., de Groot, L. R., Smith, V. D., Rangarajan, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042823 · Cited by 303
Self-citationWhite matter astrocytes in health and disease
Lundgaard, I., Osório, M. J., Kress, B. T., Sanggaard, S., & Nedergaard, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.050 · Cited by 290
Metadata
- Authors
- Bugiani, M., Boor, I., van Kollenburg, B., Postma, N., Polder, E., van Berkel, C., van Kesteren, R. E., Windrem, M. S., Hol, E. M., Scheper, G. C., Goldman, S. A., & van der Knaap, M. S.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-01
- Volume
- 70
- Issue
- 1
- Pages
- 69-82
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W2051698120
- Cited by
- 137
- References
- 12
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Defective Glial Maturation in Vanishing White Matter Disease. https://app.cochat.ai/papers/10.1097/nen.0b013e318203ae74
- The paper
- Bugiani, M., Boor, I., van Kollenburg, B., Postma, N., Polder, E., van Berkel, C., van Kesteren, R. E., Windrem, M. S., Hol, E. M., Scheper, G. C., Goldman, S. A., & van der Knaap, M. S. (2011). Defective Glial Maturation in Vanishing White Matter Disease. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1097/nen.0b013e318203ae74
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.